1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Induced Pluripotent Stem Cells: new trials by email Literature Review of Induced Pluripotent Stem Cells trials Research Report on Induced Pluripotent Stem Cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety | Phase 2 | Not yet recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 60 | 2028-05-25 | 2025-11-25 |
Central Nervous System Diseases (1) · Nervous System Diseases (1) · Spinal Cord Diseases (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. (1)
China (1)